PPT-Biomarkers & Pharmacogenomics

in CNS disorders Subbu Apparsundaram PhD CSO V ClinBio subbuvclinbiocom 1 862 485 7489 wwwvclinbiocom Sri Ramachandra University Porur Chennai India omics based prediction of drug response profiling. Raghu Kannan. “THE NEW . GOLD STANDARD. . IN . COMPANION . DIAGNOSTICS”. Introductory Slide. Current methods of detection. IHC: . Dako. –in accurate. PCR –amplifies . all . genes . FISH –works well; however, microscopic visualization of tumor regions is difficult. in CNS disorders. Subbu. . Apparsundaram. , PhD. CSO, V . ClinBio. subbu@vclinbio.com. +1 862 485 7489. www.vclinbio.com. Sri Ramachandra University. Porur. , Chennai, India. . omics. based prediction of drug response profiling. A Rigorous Discovery-Validation Path Was Taken. 2. Discovery Study. 340 proteins analyzed . (. including KIM-1, urine NGAL, plasma NGAL, . Cystatin. -C, IL-18, pi-GST, and L-FABP). Validation Study. Primary Endpoint: moderate to severe AKI (KDIGO stage 2-3) within 12 hours of . James L. Cook, DVM, . PhD. Director, Comparative Orthopaedic Lab & . Mizzou. . BioJoint. Center. cookjl@health.missouri.edu. Osteoarthritis (OA): . Everyone’s Problem. Markets. Canine. 78M companion dogs in US (2015 APPA Survey). Mike Chapman. University of Cambridge Department of Haematology. Novel agents have improved survival. What is a biomarker?. “A characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention”. and Their Relationship to Health. Mark Pettus MD. Medical Director Functional Formularies. Director Medical Education, Wellness and Population Health. Berkshire . H. ealth Systems. Learning Objectives. Expanding the Horizons. Basics of Biomarkers in RA. Biomarkers in ACR/EULAR RA Criteria. Discordance of Common RA Biomarkers. RA Practice Performance Project (RAPP). Framing the Discussion. Using ACPA Testing to Diagnose RA. Paul Dagum, MD PhD. Mindstrong Health. National Alliance in Mental Health. Washington, CD. June 30, 2017 . CHALLENGES IN MENTAL HEALTH. LACK OF MEASUREMENT. Episodic, subjective measures in laboratory environments lack sensitivity — may fail to detect clinical change . Disease. NGAL and Cystatin C. COL SOHAIL SABIR. HOD NEPHROLOGY MILITARY HOSPITAL. HOD MEDICAL EDUCATION . ARMED . FORCES POSTGRADUATE MEDICAL INSTITUTE. Biomarker. characteristic . that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or pharmacologic responses to a therapeutic intervention. Filipa Mendes. Center. for Nuclear Sciences . and. Technologies. IST, Universidade de Lisboa .  . Summer school . Development and Pre-clinical Evaluation of Radiopharmaceuticals. Molecular . and. Cell . Schistosoma mansoni. in . Biomphalaria glabrata. Benson Otarigho. 1,3. ,. , . Leandro Xavier Neves. 2. , . Ananda. Lima Sanson. 2. , . Mofolusho. O. Falade. 1. , William Castro-Borges. 2. 1. Cellular Parasitology . Optimist. Department of Biochemistry, Molecular Biology and Biophysics. Institute on Biology of Aging and Metabolism. lniedern. @. umn.edu. Utility of mice in biomarker discovery. Strength . of mice. Pragya Kumari. 1. , . Atanu. Bhattacharjee. 2. , Gajendra K. Vishwakarma. 1. 1. Indian Institute of Technology (ISM) Dhanbad, India, 826004. 2. Institute of . Acturial. . Sceience. and Data Analytics, UCSI University, Malaysia, 56000. Leyen. Vu, DO. Sept. 8. th. , 2018. WSU Cougar Health Services. WSU Athletics Team Physician. Objectives. Need for objective measures for concussion. Identify characteristics of ideal serum biomarkers for concussion.